Wellington Management Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-55,458
Closed -$1.15M 2117
2019
Q4
$1.15M Sell
55,458
-533,647
-91% -$9M ﹤0.01% 1674
2019
Q3
$8.07M Sell
589,105
-11,498
-2% -$136K ﹤0.01% 1229
2019
Q2
$7.39M Sell
600,603
-81,730
-12% -$943K ﹤0.01% 1286
2019
Q1
$8.52M Sell
682,333
-212,227
-24% -$2.84M ﹤0.01% 1248
2018
Q4
$10.1M Buy
894,560
+332,147
+59% +$5.21M ﹤0.01% 1180
2018
Q3
$10.5M Buy
562,413
+47,938
+9% +$1.1M ﹤0.01% 1266
2018
Q2
$13.3M Buy
514,475
+95,678
+23% +$2.48M ﹤0.01% 1198
2018
Q1
$9.38M Buy
418,797
+3,380
+0.8% +$82.5K ﹤0.01% 1296
2017
Q4
$10.4M Sell
415,417
-243,128
-37% -$5.95M ﹤0.01% 1260
2017
Q3
$15.9M Buy
658,545
+12,140
+2% +$285K ﹤0.01% 1140
2017
Q2
$13.1M Sell
646,405
-31,821
-5% -$663K ﹤0.01% 1143
2017
Q1
$18.3M Hold
678,226
﹤0.01% 1059
2016
Q4
$12.9M Buy
678,226
+40,420
+6% +$772K ﹤0.01% 1128
2016
Q3
$12.5M Sell
637,806
-10,590
-2% -$179K ﹤0.01% 1110
2016
Q2
$9.7M Buy
648,396
+89,793
+16% +$1.13M ﹤0.01% 1150
2016
Q1
$5.14M Sell
558,603
-732,642
-57% -$8.88M ﹤0.01% 1352
2015
Q4
$24.9M Buy
1,291,245
+32,531
+3% +$565K 0.01% 898
2015
Q3
$18.7M Buy
1,258,714
+1,037,290
+468% +$24.3M 0.01% 998
2015
Q2
$4.85M Buy
+221,424
New +$4.47M ﹤0.01% 1414

Other funds holding FLXN

Wellington Management Group's FLXN Position: Q1 2020 in Review

Wellington Management Group sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2020, closing a stake of 55,458 shares — an estimated $1.15M sold.

Wellington Management Group first reported a position in FLXN in Q2 2015 and held it in 19 quarters. The position peaked at $24.9M in Q4 2015. 123 funds tracked by Wall St. Rank hold FLXN as of Q1 2020.

  • Wellington Management Group reported no remaining Flexion Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
  • Wellington Management Group sold 55,458 Flexion Therapeutics, Inc. shares in Q1 2020, an estimated $1.15M.
  • Wellington Management Group first reported a position in Flexion Therapeutics, Inc. in Q2 2015 and held it in 19 quarters.
  • Wellington Management Group's Flexion Therapeutics, Inc. position peaked at $24.9M in Q4 2015.
  • 123 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2020.

Based on Wellington Management Group's 13F filing for Q1 2020, filed 14 May 2020.